top of page

Converting infused medicines into subcutaneous injections, including PD-1s, with Halozyme

Halozyme CEO Helen Torley describes the technology behind converting infused medicines into subcu shots and how it impacts a patient’s experience.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page